The hosts of Morning Brew Daily made a simple argument on a recent episode that the idea of the “Ozempic economy” should be ...

The company still has a strong lead in its core therapeutic area.

GLP Diet app review pieces are popping up at the same moment interest in Ozempic and other GLP-1 drugs is beginning to cool, ...

The unchanged US$9.88 fair value estimate for LifeMD keeps the core price target steady, even as model inputs see only marginal tweaks. That stability lines up with recent analyst debate around Q4 ...

The $63-billion GLP-1 agonist industry is forecast to triple in the coming decade, so it's no surprise that pharmaceuticals ...

The weight loss drugs are impacting the restaurant behavior of consumers in different ways, and sometimes it divides along ...

The Centers for Medicare & Medicaid Services (CMS) has announced that its temporary program to cover GLP-1 drugs for obesity in Medicare.

Core Progression Elite Personal Training ("Core Progression") and Vitelize Health ("Vitelize") have launched a coordinated GLP-1 weight-loss model that places independent, physician-directed clinics ...

A weight management doctor and exercise physiologist share three strength exercises to prevent GLP-1 muscle loss.

Experts describe the development of oral GLP-1 medication as a “pivotal” improvement in the accessibility and adherence to obesity drugs. As of February 2026, only Wegovy and Rybelsus are available in ...

Could drugs like Mounjaro treat people with cannabis use disorder? They might. Preliminary research indicates they may stop ...